Ovid Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 10.71 M | $23.79 M | 0.00% | 14.53% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 10.71 M | $23.73 M | 100.00% | 14.53% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 10.64 M | $23.61 M | 48.76% | 14.42% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 9.92 M | $22.02 M | 131.43% | 13.45% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 6.16 M | $13.68 M | 76.51% | 8.36% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 5.53 M | $12.28 M | 1,602.48% | 7.50% |
| 05/15/2026 | 5.26 M | $11.67 M | 100.00% | 7.13% | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 4.54 M | $10.09 M | 6.05% | 6.16% |
| SATURN V CAPITAL MANAGEMENT LLC | 05/15/2026 | 4.17 M | $9.25 M | 66.67% | 5.65% |
| FEDERATED HERMES, INC. | 05/11/2026 | 3.57 M | $7.93 M | 0.00% | 4.84% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 2.89 M | $6.43 M | 1,069.30% | 3.93% |
| ALLY BRIDGE GROUP (NY) LLC | 05/18/2026 | 2.82 M | $6.26 M | 57.90% | 3.82% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.95 M | $4.32 M | 469.91% | 2.64% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/14/2026 | 1.90 M | $4.23 M | 100.00% | 2.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 1.62 M | $3.60 M | 100.00% | 2.20% |
| BLACKROCK, INC. | 05/13/2026 | 1.53 M | $3.40 M | 149.93% | 2.08% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.50 M | $3.32 M | 11.73% | 2.03% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 1.32 M | $2.93 M | -62.81% | 1.79% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.32 M | $2.93 M | 96.14% | 1.79% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.26 M | $2.79 M | 109.87% | 1.70% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 1.25 M | $2.78 M | -12.27% | 1.70% |
| ROSALIND ADVISORS, INC. | 05/14/2026 | 1.11 M | $2.46 M | 100.00% | 1.50% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 1.10 M | $2.45 M | -25.61% | 1.50% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 1.00 M | $2.22 M | 100.00% | 1.36% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 927.91 K | $2.06 M | 495.81% | 1.26% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 921.46 K | $2.04 M | 100.00% | 1.25% |
| MARSHALL WACE, LLP | 05/15/2026 | 917.73 K | $2.04 M | -27.82% | 1.24% |
| JANE STREET GROUP, LLC | 05/12/2026 | 735.43 K | $1.63 M | -16.79% | 1.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 713.63 K | $1.58 M | -1.00% | 0.97% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 693.26 K | $1.54 M | 100.00% | 0.94% |
| STATE STREET CORP | 05/15/2026 | 520.28 K | $1.16 M | 88.15% | 0.71% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 443.36 K | $984.26 K | -16.35% | 0.60% |
| CITADEL ADVISORS LLC | 05/15/2026 | 367.90 K | $816.74 K | -53.89% | 0.50% |
| SEI INVESTMENTS CO | 05/13/2026 | 328.92 K | $730.21 K | 100.00% | 0.45% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 290.43 K | $644.76 K | 49.02% | 0.39% |
| UBS GROUP AG | 05/05/2026 | 277.66 K | $616.40 K | 43.87% | 0.38% |
| EAM INVESTORS, LLC | 05/13/2026 | 270.30 K | $600.06 K | 100.00% | 0.37% |
| NORTHERN TRUST CORP | 05/14/2026 | 254.80 K | $565.67 K | 52.92% | 0.35% |
| CIBC WORLD MARKET INC. | 05/14/2026 | 249.35 K | $553.56 K | 100.00% | 0.34% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/20/2026 | 227.74 K | $505.59 K | -63.15% | 0.31% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 212.21 K | $471.11 K | 10.24% | 0.29% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 208.21 K | $462.22 K | 3.57% | 0.28% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 197.97 K | $439.50 K | 407.18% | 0.27% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 160.00 K | $355.20 K | 0.00% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 159.30 K | $353.65 K | 1,013.99% | 0.22% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 152.85 K | $339.32 K | -10.33% | 0.21% |
| VERDAD ADVISERS, LP | 05/15/2026 | 151.92 K | $337.26 K | 100.00% | 0.21% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 130.81 K | $290.41 K | 100.00% | 0.18% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 123.97 K | $275.00 K | 14.43% | 0.17% |
| CITIGROUP INC | 05/11/2026 | 114.24 K | $253.62 K | 2,319.87% | 0.15% |
Ovid Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 132 institutional investors and hedge funds held shares of Ovid Therapeutics Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.71 M
JANUS HENDERSON GROUP PLC: 10.71 M
Affinity Asset Advisors, LLC: 10.64 M
EVENTIDE ASSET MANAGEMENT, LLC: 9.92 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 6.16 M
BALYASNY ASSET MANAGEMENT L.P.: 5.53 M
142.49% of Ovid Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 116.97 M shares in the last 24 months. This purchase volume represents approximately $250.32 M in transactions.